Identifying potential drug targets and biomarkers for CORIN, a heart-specific serine proteinase

Target Name: CORIN

NCBI ID: G10699

CORIN

Identifying potential drug targets and biomarkers for CORIN, a heart-specific serine proteinase

Abstract:

CORIN (cardiac specific serine protease) is a protein that is expressed in the heart and is involved in the regulation of various physiological processes that are critical for heart function. Despite its crucial role, the regulation of CORIN is still not well understood. Identifying potential drug targets and biomarkers for CORIN could provide valuable insights into the underlying mechanisms of heart disease and may lead to the development of new therapeutic approaches. In this article, we will discuss the current understanding of CORIN and its potential drug targets, as well as the potential utility of CORIN as a biomarker for heart disease.

Introduction:

Cardiovascular disease is a leading cause of morbidity and mortality worldwide, placing a significant burden on healthcare systems. The heart is a vital organ that plays a critical role in maintaining the circulatory system, and it is essential that the heart function properly to maintain blood flow and oxygen supply to the body's tissues. The regulation of various physiological processes that are critical for heart function is critical for maintaining the heart's health. One of the key proteins involved in this regulation is CORIN (cardiac specific serine protease).

CORIN is a 26 kDa protein that is expressed in the heart and is involved in the regulation of various physiological processes that are critical for heart function, including cell signaling, cell adhesion, and cell proliferation. It is a key enzyme in the regulation of myocardial contractions and myocardial fibrosis, and it has been implicated in the development and progression of various cardiovascular diseases, including heart failure, hypertension, and cancer.

Potential Drug Targets:

CORIN is a protein that has been identified as a potential drug target for various cardiovascular diseases. Several studies have shown that the levels of CORIN are altered in various cardiovascular conditions, including heart failure, hypertension, and cancer, and that it is involved in the development and progression of these conditions.

One of the potential drug targets for CORIN is the regulation of myocardial contractions. Myocardial contractions are critical for maintaining blood flow and oxygen supply to the body's tissues, and the regulation of myocardial contractions is critical for maintaining the heart's health. Several studies have shown that the levels of CORIN are altered in various myocardial conditions, including heart failure, and that it is involved in the regulation of myocardial contractions. Therefore, targeting CORIN with drugs that can modulate its activity could be a potential approach for the treatment of cardiovascular disease.

Another potential drug target for CORIN is the regulation of myocardial fibrosis. Myocardial fibrosis is the excessive accumulation of extracellular matrix (ECM) components in the heart, which can lead to the loss of heart function and the development of various cardiovascular diseases. The regulation of myocardial fibrosis is critical for maintaining the heart's health, and the levels of CORIN are known to be involved in this regulation. Therefore, targeting CORIN with drugs that can modulate its activity could be a potential approach for the treatment of myocardial fibrosis.

Biomarkers:

CORIN is also a protein that has the potential to serve as a biomarker for various cardiovascular diseases. The levels of CORIN are known to be involved in the regulation of various physiological processes that are critical for heart health, including myocardial contractions and myocardial fibrosis. Therefore, the levels of CORIN can be used as a biomarker for the diagnosis and monitoring of various cardiovascular diseases.

One approach to using CORIN as a biomarker for

Protein Name: Corin, Serine Peptidase

Functions: Serine-type endopeptidase involved in atrial natriuretic peptide (NPPA) and brain natriuretic peptide (NPPB) processing (PubMed:10880574, PubMed:21288900, PubMed:20489134, PubMed:21763278). Converts through proteolytic cleavage the non-functional propeptides NPPA and NPPB into their active hormones, ANP and BNP(1-32) respectively, thereby regulating blood pressure in the heart and promoting natriuresis, diuresis and vasodilation (PubMed:10880574, PubMed:21288900, PubMed:20489134, PubMed:21763278). Proteolytic cleavage of pro-NPPA also plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus (PubMed:22437503). Also acts as a regulator of sodium reabsorption in kidney (By similarity)

The "CORIN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CORIN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets